Merrimack Pharmaceuticals Priced, Nasdaq: MACK
Uses its Network Biology system to discover and develop cancer treatments.
Industry: Health Care
First Day Return: -13.7%
Industry: Health Care
| IPO Data | |
|---|---|
| IPO File Date | 07/08/2011 |
| Offer Price | $7.00 |
| Price Range $7.00 - $7.00 | |
| Offer Shares (mm) | 14.3 |
| Deal Size ($mm) | $100 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 03/28/2012 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $100 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Cambridge, MA, United States |
| Founded | 1993 |
| Employees at IPO | 218 |
| Website www.merrimackpharma.com | |
Merrimack Pharmaceuticals (MACK) Performance
